Purpose
Biofeedback is well established as a treatment for fecal incontinence but little is known about factors that may be associated
with its effectiveness. This study assessed short-term outcomes, predictors of patients who completed treatment, and predictors
of treatment success.
Methods
This study was a retrospective review of consecutive patients treated with biofeedback at a tertiary referral colorectal clinic
during ten years. Clinical, physiologic, and quality of life measures were collected prospectively at the time of treatment.
Regression analysis was performed.
Results
Of 513 patients, 385 (75 percent) completed the treatment program. Each outcome was improved for more than 70 percent of patients.
Incontinence scores decreased by 32 percent (from 7.5 to 5.2 of 13), patient assessment of continence increased by 40 percent
(from 5.3 to 3.2 of 10), quality of life improved by 89 percent (from 0.34 to 0.67 of 1.0), and maximum anal sphincter pressure
increased by a mean 12 mmHg (14 percent; from 90 to 102 mmHg). Patients who did not complete treatment were younger, were
more likely to be male, and had less severe incontinence. Treatment success was predicted by completion of all treatment sessions
(odds ratio, 10.34; 95 percent confidence interval, 4.46–24.19), female gender (odds ratio, 4.11; 95 percent confidence interval,
1.04–7.5), older age (odds ratio, 1.02 per year; 95 percent confidence interval, 1–1.04), and more severe incontinence before
treatment (odds ratio, 1.19 per unit increase in St. Mark’s score; 95 percent confidence interval, 1.05–1.34).
Conclusions
More than 70 percent of patients in this large series demonstrated improved short-term outcomes. Treatment success was more
likely in those who completed six training sessions, were female, older, or had more severe incontinence. Patients were less
likely to complete treatment if they were male, younger, or had milder incontinence.
Key words Fecal incontinence - Anal - Biofeedback - Randomized - Controlled trial - Clinical trial - Quality of life
Dr. Byrne was supported by the Notaras Fellowship from the University of Sydney, the Scientific Foundation of the Royal Australasian
College of Surgeons, and the training board of the Colorectal Society of Australasia.
Presented at the Tripartite Colorectal Meeting, Dublin, Ireland, July 5 to 7, 2005.
Reprints are not available.